Sandler Alan B.
SEC CIK 1835966 · EDGAR
BoughtSold
Most active insiders at RVMD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GOLDSMITH MARK A | See Remarks, Dir | — | $56.99M |
| 2 | Kelsey Stephen Michael | See Remarks | — | $22.55M |
| 3 | Cislini Jeff | SVP, GC | — | $15.11M |
| 4 | Kim Lorence H. | Dir | — | $14.97M |
| 5 | Horn Margaret A | COO | — | $10.84M |
| 6 | Mancini Anthony | See Remarks | — | $9.05M |
| 7 | Anders Jack | CFO | — | $7.13M |
| 8 | ANDERSON ELIZABETH M | Dir | — | $1.96M |
| 9 | Patel Sushil | Dir | — | $1.05M |
| 10 | Wei Lin | Chief Medical Off | — | $206.2K |
| 12 | Sandler Alan B. | Chief Development Off | — | $67.9K |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-09-18 18:06 | 2026-09-16 | RVMD | Revolution Medicines, Inc. | Sandler Alan B. | Chief Development Off | S - Sale | $199.24 | -341 | 52.9K | -0.6% | -$67.9K |
| D | 2022-04-05 | 2022-04-01 | ZLAB | Zai Lab Ltd | Sandler Alan B. | Head of Gbl Dev, Oncology | M - OptEx | $0.00 | +1,060 | 29.0K | +4% | $0 |
| 2021-12-03 | 2021-12-01 | ZLAB | Zai Lab Ltd | Sandler Alan B. | Head of Gbl Dev, Oncology | F - Tax | $71.23 | -2,075 | 27.9K | -7% | -$147.8K |
Purchase Sale Sale after option exercise All abbreviations